Gilead Sciences GILD Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

16.7%+8.4pp

IncyteINCY

62.6%+24.7pp

PrecigenPGEN

-204.2%-592pp

AnaptysBio, Inc.ANAB

-255.3%-510pp

Iovance Biotherapeutics, Inc.IOVA

-59.5%-2.6pp

CelcuityCELC

-168.1%-1,894pp

FAQ

What is Gilead Sciences's return on invested capital?

Gilead Sciences (GILD) reported return on invested capital of 23.7% in Q1 2026.

How has Gilead Sciences's return on invested capital changed year-over-year?

Gilead Sciences's return on invested capital increased by 22.5% year-over-year, from 19.4% to 23.7%.

What is the long-term trend for Gilead Sciences's return on invested capital?

Over 5 years (2020 to 2025), Gilead Sciences's return on invested capital has grown at a 34.5% compound annual growth rate (CAGR), from 5.1% to 22.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.